7 unknown. 7 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Unknown 7 |
| Phase 2 | 1 | Unknown 1 |
Follow endostar: new trials by email Literature Review of endostar trials Research Report on endostar
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Efficacy and Safety of Endostar Combined With Taxane-based Regimens for HER-2-negative MBC Patients endostar - Angiogenesis, Breast Cancer | Phase 3 | Unknown | Fujian Cancer Hospital | 80 | 2016-12-01 | 2016-08-12 |
| Endostar Combined With Concurrent Chemoradiotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma Endostar, DDP - Nasopharyngeal Carcinoma | Phase 3 | Unknown | First Affiliated Hospital of Guangxi Medical University | 300 | 2016-10-01 | 2016-09-20 |
| Systemic Chemotherapy Combined With Recombinant Human Adenovirus Type 5 and Endostatin Injections for Treatment Malignant Hydrothorax in NSCLC Patients Gemcitabine, Vinorelbine, Paclitaxel - Malignant Hydrothorax, Non Small Cell Lung Cancer | Phase 3 | Unknown | Xinqiao Hospital of Chongqing | 134 | 2016-10-01 | 2016-10-21 |
| Endostar Combination With Chemotherapy and EGFR-TKI in Lung Cancer Rechallenging Treatment After Acquired Resistance. Recombinant human endostatin, Placebo - Lung Cancer | Phase 2 / Phase 3 | Unknown | Peking University Third Hospital | 60 | 2014-01-01 | 2015-01-29 |
| Comparison of Postoperative Adjuvant Chemotherapy With/Without Rh-endostatin on Non-small Cell Lung Cancer in PhaseⅠB Pemetrexed, Docetaxel, rh-Endostatin - Non-small Cell Lung Cancer | Phase 3 | Unknown | Xinjiang Medical University | 392 | 2013-10-01 | 2013-12-04 |
| Impact of Endostar Combined With Chemotherapy on the Angiogenesis of Advanced Non-small Cell Lung Cancer (NSCLC) Treated by endostar combined with docetaxel and cisplatin, Treated by docetaxel and cisplatin - Lung Neoplasms | Phase 3 | Unknown | Xijing Hospital | 80 | 2008-04-01 | 2010-09-17 |
| Adjuvant Vinorelbine Plus Cisplatin (NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer recombinant human endostatin - Non-small Cell Lung Cancer | Phase 3 | Unknown | Chinese Academy of Sciences | 1108 | 2007-06-01 | 2010-03-09 |
Carcinoma, Non-Small-Cell Lung (3) · Lung Neoplasms (2) · Breast Neoplasms (1) · Nasopharyngeal Carcinoma (1)
Chinese Academy of Sciences (1) · First Affiliated Hospital of Guangxi Medical University (1) · Fujian Cancer Hospital (1) · Peking University Third Hospital (1) · Xijing Hospital (1) · Xinjiang Medical University (1) · Xinqiao Hospital of Chongqing (1)
China (5)
Changgui Wu, MD, PHD (1) · Jie He, M.D. & Ph.D. (1) · Li Liang, MD (1) · Pang Zuoliang, Postgraduate (1)
PMID 10640954, PMID 11212235, PMID 15746043, PMID 15752890, PMID 15920746, PMID 16139912, PMID 19564532